Skip to main content

Kazi Tasneem, Ph.D., Preclinical Senior Scientist, Genentech Inc.

Kazi Tasneem is a Preclinical Senior Scientist at Genentech Inc., specializing in antibody drug development with over 3 years of industry experience. She focuses on computational prediction models for drug transport in preclinical settings, overseeing the design/strategy and interpretation of pharmacokinetics/pharmacodynamics studies for antibody/biologics in cancer immunotherapy. She holds a PhD in Chemical Engineering from Vanderbilt University, a Master’s degree in Materials Science and Engineering from the University of Central Florida and a Master’s degree in Environmental Engineering from Carnegie Mellon University. 

She completed her Bachelor’s degree in Chemical Engineering from Bangladesh University of Engineering and Technology (BUET). Kazi is an Advisory Council Member of the Engineering Leadership Program at California State University, Chico. She has received prestigious awards, including the Best Abstract Award for biological modeling from the Society of Toxicology and two Best Research Paper Awards from Vanderbilt University and The Minerals, Metals, & Materials Society. She co-owns a US Patent for a novel design of human organ-on-chip. She was one of the Grace Hopper Celebration Student Scholars of Women in Computing at Anita Borg Institute. She was also honored with the Young Researcher award from Bangladesh, enabling her attendance at the 59th Meeting of Nobel Prize Winners in Chemistry.

Throughout her academic and professional career, Kazi has demonstrated leadership and community involvement, including active roles as Graduate Chair/Professional Development Chair in professional societies like the Society of Women Engineers and the Society of Toxicology, earning recognition such as Guiding Star Award at Society of Women Engineers. Kazi served as Speaker/Co-panelists at a webinar “Career in MedTech” organized by Systers Bangladesh, AnitaBorg Institute.

Comments

Post a Comment

Popular posts from this blog

Sachi Ahmed, Senior Scientist, Merck & Co.

Sachi Ahmed is a senior scientist at Merck & Co. working on ADCs and bispecifics. With a background in chemical engineering, she has been a researcher in the field of cancer for 20 years and is a published author in scientific journals, including a publication in Nature magazine on nasal delivery of an IgM drug for SARS-CoV-2 variants . Sachi is also a key inventor on a US patent for glyco-engineered IgMs .  Prior to Merck, she was at IGM biosciences for 7 years where she led the research antibody production team focused on novel approaches in cancer and Covid-19 therapeutics. She has also previously worked for biotechnology companies such as Abbott, Abbvie, and Merck and has expertise in in-vitro glycoengineering and antibody production to support the development of innovative biologics. Sachi was a founder of the PTPS (Peers Teaching Peers Science) program at the FAME Charter School in Fremont, CA, aimed to inspire children to gain confidence and interest in science and engineeri
Post a Comment
Read more

Tahmida Mahmud, Ph.D., Director of Engineering, AI, Nauto

Tahmida Mahmud is the Director of Engineering, AI at Nauto, Inc leading both the Perception & Data Science teams. The teams develop AI-based algorithms related to critical external safety features (ADAS) and driver monitoring system (DMS) for automotive fleets focusing on development, large-scale deployment, and monitoring of machine learning/deep learning solutions to mitigate distracted driving, prevent collisions, model risk, coach drivers, and contribute to the advancement of self-driving technology. She received her Masters and Ph.D. in Electrical Engineering from University of California, Riverside. Her research focus is computer vision and machine learning and she has several publications in her field. She finished her Bachelors in Electrical and Electronic Engineering from Bangladesh University of Engineering and Technology (BUET).  She was listed as one of the 30 influential women advancing AI in 2020 by ReWork. Apart from her passion to use technology to have a real impac
Post a Comment
Read more